InterpaceBiosciences_New Logo.png
Interpace Pharma Solutions Announces New Capability in Spatial Biology/Precision Oncology Services
May 17, 2021 08:00 ET | Interpace Biosciences, Inc.
Parsippany, NJ, May 17, 2021 (GLOBE NEWSWIRE) -- Interpace Pharma Solutions, a subsidiary of Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) announced today that it will...
InterpaceBiosciences_New Logo.png
Interpace Biosciences to Explore Strategic Alternatives for Maximizing Shareholder Value
April 22, 2021 08:00 ET | Interpace Biosciences, Inc.
Parsippany, NJ, April 22, 2021 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) today issued the following statement. Interpace continues to make...
LOGO.jpg
Interpace Biosciences’ Audit Committee Investigation Finds Complaints Unsubstantiated
October 14, 2020 06:30 ET | Interpace Biosciences, Inc.
PARSIPPANY, NJ, Oct. 14, 2020 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (Nasdaq: IDXG) announced today that the Audit Committee of the Board of Directors has...
LOGO.jpg
Interpace Biosciences to Host Conference Call and Webcast to Discuss First Quarter, 2020 Financial Results on Thursday June 25, 2020
June 24, 2020 16:20 ET | Interpace Biosciences, Inc.
PARSIPPANY, NJ, June 24, 2020 (GLOBE NEWSWIRE) -- Interpace Biosciences (IDXG) announced today that it will report its first quarter, 2020 financial results on Thursday, June 25, 2020 at 4:30 p.m....
LOGO.jpg
Interpace Biosciences Announces Contract with Lab Benefits Management Firm
April 27, 2020 06:55 ET | Interpace Biosciences, Inc.
In-Network Access for More Than 3 Million Members Parsippany, NJ, April 27, 2020 (GLOBE NEWSWIRE) -- Interpace Biosciences (NASDAQ: IDXG) announced today that its subsidiary, Interpace...
LOGO.jpg
Interpace Biosciences Announces Acceptance of first paper Demonstrating Clinical Performance of ThyGeNEXT with ThyraMIR
March 02, 2020 06:55 ET | Interpace Biosciences, Inc.
Parsippany, NJ, March 02, 2020 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (Nasdaq: IDXG) today announced acceptance of the first manuscript reporting the clinical performance of the company’s...
Fior-Markets-Logo.jpg
Global Medical Vaccum Market is Expected to Reach USD 1.88 Billion by 2026 : Fior Markets
August 28, 2019 09:34 ET | Fior Markets
New Jersey, NJ, Aug. 28, 2019 (GLOBE NEWSWIRE) -- Growing geriatric population world over, technological progress in the vacuum systems, increasing number of diagnostic imaging procedures,...
Logo.png
Interpace Diagnostics to Host Conference Call and Webcast to Discuss Second Quarter 2019 Financial Results on Tuesday, August 13, 2019
August 06, 2019 16:05 ET | Interpace Diagnostics Group, Inc.
PARSIPPANY, NJ, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today that it will report its second quarter 2019 financial results on Tuesday, August...
Logo-BCC-Research.jpg
Growth in Neuroprotective Agents Market Projected to 2022
June 18, 2018 06:00 ET | BCC Research
WELLESLEY, Mass., June 18, 2018 (GLOBE NEWSWIRE) -- Longer life spans, the increasing prevalence of neurological disorders (particularly neurodegenerative diseases), stroke and traumatic central...